Skip to Content

AmericaFirst Defensive Growth I DGQIX

Medalist Rating as of | See America First Investment Hub
  • NAV / 1-Day Return 8.54  /  −0.12 %
  • Total Assets 1.0 Mil
  • Adj. Expense Ratio
    2.340%
  • Expense Ratio 2.340%
  • Distribution Fee Level High
  • Share Class Type Institutional
  • Category Long-Short Equity
  • Investment Style Large Blend
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield
  • Turnover 501%

USD | NAV as of Apr 26, 2024 | 1-Day Return as of Apr 26, 2024, 10:14 PM GMT+0

Morningstar’s Analysis DGQIX

Will DGQIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in AmericaFirst Defensive Growth I's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DGQIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 52.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Cash & Cash Equivalents

11.99 128,454
Cash and Equivalents

Eli Lilly and Co

8.28 88,687
Healthcare

Costco Wholesale Corp

5.54 59,343
Consumer Defensive

PepsiCo Inc

5.29 56,703
Consumer Defensive

Novo Nordisk A/S ADR

5.27 56,496
Healthcare

McKesson Corp

4.96 53,148
Healthcare

International Business Machines Corp

4.90 52,514
Technology

RTX Corp

4.90 52,471
Industrials

Thermo Fisher Scientific Inc

4.56 48,822
Healthcare

Visa Inc Class A

4.43 47,444
Financial Services